User profiles for Diarra Bassirou

Bassirou Diarra, MD, MSc, PhD

SEREFO/UCRC, University Clinical Research center, University of sciences, techniques and
Verified email at icermali.org
Cited by 2067

A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa

…, D Doolabh, D Ssemwanga, D Tshiabuila, D Bassirou… - Science, 2021 - science.org
The progression of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
pandemic in Africa has so far been heterogeneous, and the full impact is not yet well understood…

The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance

…, BL Salako, BS Oderinde, B Bolajoko, B Diarra… - Science, 2022 - science.org
Investment in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sequencing
in Africa over the past year has led to a major increase in the number of sequences that have …

Efflux inhibition with verapamil potentiates bedaquiline in Mycobacterium tuberculosis

…, KA Cohen, K Winglee, M Maiga, B Diarra… - Antimicrobial agents …, 2014 - Am Soc Microbiol
Drug efflux is an important resistance mechanism in Mycobacterium tuberculosis . We found
that verapamil, an efflux inhibitor, profoundly decreases the MIC of bedaquiline and …

[HTML][HTML] Failure to recognize nontuberculous mycobacteria leads to misdiagnosis of chronic pulmonary tuberculosis

M Maiga, S Siddiqui, S Diallo, B Diarra, B Traoré… - PloS one, 2012 - journals.plos.org
Background Nontuberculous mycobacterial (NTM) infections cause morbidity worldwide.
They are difficult to diagnose in resource-limited regions, and most patients receive empiric …

Towards host-directed therapies for tuberculosis

…, M Bonnet, C Menendez, TN Dieye, B Diarra… - Nature reviews Drug …, 2015 - nature.com
The treatment of tuberculosis is based on combinations of drugs that directly target
Mycobacterium tuberculosis. A new global initiative is now focusing on a complementary …

[HTML][HTML] Clinical risk factors associated with multidrug-resistant tuberculosis (MDR-TB) in Mali

…, B Kone, Y Toloba, DK Dabitao, B Diarra… - International Journal of …, 2019 - Elsevier
Background MDR-TB is a major threat to global TB control. In 2015, 580,000 were treated
for MDR-TB worldwide. The worldwide roll-out of GeneXpert MTB/RIF ® has improved …

[HTML][HTML] The emerging threat of pre-extensively drug-resistant tuberculosis in West Africa: preparing for large-scale tuberculosis research and drug resistance …

…, A Ba-Diallo, P Rabna, M Mane, M Sanogo, B Diarra… - BMC medicine, 2016 - Springer
Background Drug-resistant tuberculosis (TB) is a global public health problem. Adequate
management requires baseline drug-resistance prevalence data. In West Africa, due to a poor …

Comparing accuracy of lipoarabinomannan urine tests for diagnosis of pulmonary tuberculosis in children from four African countries: a cross-sectional study

…, II Abok, JT Angyu, A Diakité, B Diarra… - The Lancet Infectious …, 2021 - thelancet.com
Background A sensitive and specific non-sputum-based test would be groundbreaking for
the diagnosis of childhood tuberculosis. We assessed side by side the diagnostic accuracy of …

[HTML][HTML] Evolution of Mycobacterium tuberculosis complex lineages and their role in an emerging threat of multidrug resistant tuberculosis in Bamako, Mali

M Senghore, B Diarra, F Gehre, J Otu, A Worwui… - Scientific reports, 2020 - nature.com
In recent years Bamako has been faced with an emerging threat from multidrug resistant TB
(MDR-TB). Whole genome sequence analysis was performed on a subset of 76 isolates …

[HTML][HTML] Antituberculosis therapy and gut microbiota: review of potential host microbiota directed-therapies

…, B Baya, A Kone, YS Sarro, B Kone, B Diarra… - Frontiers in Cellular …, 2021 - frontiersin.org
Tuberculosis (TB) remains a major public health concern with millions of deaths every year.
The overlap with HIV infections, long treatment duration, and the emergence of drug …